[January 30, 2013] |
|
Vanguard Health Systems Reports Second Quarter Fiscal 2013 Results
NASHVILLE, Tenn. --(Business Wire)--
Vanguard Health Systems, Inc. (NYSE: VHS) today announced financial and
operating results for its second fiscal quarter of 2013.
Second Quarter Fiscal 2013 Key Metrics
(all percentage changes compare Q2 FY2013 to Q2 FY2012):
Consolidated and Same Store:
-
Net income attributable to Vanguard Health Systems, Inc. stockholders
was $12.2 million, or $0.14 per diluted share, compared to net income
of $15.7 million, or $0.20 per diluted share, during the prior year
period
-
Adjusted EBITDA was $137.8 million
-
Patient revenue per adjusted discharge increased 1.5 percent
-
Discharges decreased 1.4 percent
-
Adjusted discharges increased 1.4 percent
Year to Date Fiscal 2013 Key Metrics
(all percentage changes compare six months FY2013 to six months FY2012):
Consolidated:
-
Net income attributable to Vanguard Health Systems, Inc. stockholders
was $26.1 million, or $0.31 per diluted share, compared to a net loss
of $6.0 million, or $(0.08) per diluted share, during the prior year
period
-
Adjusted EBITDA increased 4.9 percent to $271.0 million
Same Store:
-
Patient revenue per adjusted discharge increased 2.3 percent
-
Discharges decreased 1.8 percent
-
Adjusted discharges decreased 0.2 percent
A reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to
net income (loss) attributable to Vanguard Health Systems, Inc.
stockholders for the quarters and six-month periods ending December 31,
2011 and 2012 is included in this release.
Second Quarter Analysis
Consolidated total revenues increased $37.7 million during the second
quarter of fiscal 2013 compared to the prior year period. Net patient
service revenues increased $33.2 million as a result of a 1.4 percent
increase in adjusted discharges and a 1.5 percent increase in patient
revenue per adjusted discharge. Emergency room visits increased 6.0
percent and observation cases increased 8.0 percent. Health plan premium
revenues increased slightly during the second quarter of fiscal 2013
compared to the prior year period. Uncompensated care as a percentage of
net patient revenues (prior to uncompensated care deductions) was 21.3
percent during the second quarter of fiscal 2013 compared to 20.0
percent during the prior year period primarily due to an increase in
uninsured discharges as a percentage of total discharges.
Fiscal Year to Date Analysis
Consolidated total revenues increased $72.1 million during the six
months ended December 31, 2012 compared to the prior year period,
primarily due to the acquisition of Valley Baptist Health System in
September 2011. Same store net patient service revenues increased 1.6
percent during the six months ended December 31, 2012 resulting from a
2.3 percent increase in patient revenue per adjusted discharge combined
with a 0.2 percent decrease in adjusted discharges. Same store emergency
room visits increased 3.8 percent and same store observation cases
increased 9.1 percent during the six months ended December 31, 2012
compared to the prior year period. Health plan premium revenues, on a
same store basis, decreased 10.4 percent during the six months ended
December 31, 2012 compared to the prior year period. Phoenix Health
Plan's revenues were negatively impacted by a combination of program
changes adopted by Arizona Health Care Cost Containment System
("AHCCCS") beginning April 1, 2011 and continuing during our fiscal year
2012, including capitation payment rate decreases, program eligibility
restrictions and health plan profitability limitations for certain
member groups.
Same store uncompensated care as a percentage of net patient revenues
(prior to uncompensated care deductions) was 20.2 percent during the six
months ended December 31, 2012 compared to 18.0 percent during the prior
year period primarily due to an increase in uninsured discharges as a
percentage of total discharges.
Balance Sheet and Cash Flows
As of December 31, 2012, we had cash of $357.8 million and total debt of
$2,703.2 million.
Cash flows from operating activities improved by $81.1 million during
the six months ended December 31, 2012 compared to the prior year
period. Changes in net operating assets and liabilities negatively
impacted operating cash flows by $92.9 million during the six months
ended December 31, 2012 compared to a negative impact of $172.2 million
during the prior year period. We made $98.2 million of interest and
income tax payments during the six months ended December 31, 2012, which
was $16.6 million higher than these payments during the prior year
period.
Capital expenditures increased 36.4 percent to $187.2 million during the
six months ended December 31, 2012 compared to the prior year period due
to increased spending related to the Detroit Medical Center specified
capital project commitments and the start of construction of a new
hospital in New Braunfels, Texas.
Outlook for Fiscal Year 2013
We are confirming our previously issued fiscal year 2013 outlook for
ranges of projected Adjusted EBITDA, projected net income attributable
to Vanguard Health Systems, Inc. stockholders, projected diluted
earnings per share and projected capital expenditures.
Earnings Conference Call
We will host a conference call at 11:00 a.m. EST on January 31, 2013.
All interested parties are invited to access a live webcast of the
conference call on the Investor Relations Section of our website at http://vanguardhealth.com.
If you are unable to participate during the live webcast, the
webcast will be available on a replay basis for 90 days.
We own and operate 28 acute care and specialty hospitals and
complementary facilities and services in metropolitan Chicago, Illinois;
metropolitan Detroit, Michigan; metropolitan Phoenix, Arizona; San
Antonio, Texas; Harlingen and Brownsville, Texas; and Worcester and
metropolitan Boston, Massachusetts. Our strategy is to develop locally
branded, comprehensive health care delivery networks in urban markets.
Cautionary Statement about Forward-Looking Information
This press release contains "forward-looking statements" within the
meaning of the federal securities laws that are intended to be covered
by safe harbors created thereby. Forward-looking statements are those
statements that are based upon management's plans, objectives, goals,
strategies, future events, future revenue or performance, capital
expenditures, financing needs, plans or intentions relating to
acquisitions, business trends and other information that is not
historical information. These statements are based upon estimates and
assumptions made by our management that, although believed to be
reasonable, are subject to numerous factors, risks and uncertainties
that could cause actual outcomes and results to be materially different
from those projected. When used in this press release, the words
"estimates," "expects," "anticipates," "projects," "plans," "intends,"
"believes," "forecasts," "continues" or future or conditional verbs,
such as "will," "should," "could" or "may," and variations of such words
or similar expressions are intended to identify forward-looking
statements. These factors, risks and uncertainties include, among
others, the following: our high degree of leverage and interest rate
risk; our ability to incur substantially more debt; operating and
financial restrictions in our debt agreements; our ability to generate
cash necessary to service our debt; weakened economic conditions and
volatile capital markets; potential adverse impact of pre-payment and
post-payment claims reviews by governmental agencies; our ability to
grow our business and successfully implement our business strategies,
including growing our ambulatory care services platform; our ability to
successfully integrate hospitals or ambulatory care facilities acquired
in the future or to recognize expected synergies from such acquisitions;
potential acquisitions could be costly, unsuccessful or subject us to
unexpected liabilities; conflicts of interest that may arise as a result
of our control by a small number of stockholders; the highly competitive
nature of the health care industry; the geographic concentration of our
operations; governmental regulation of the health care industry,
including Medicare and Medicaid reimbursement levels in general and with
respect to the impact of the Budget Control Act of 2011 and other future
deficit reduction plans; a reduction or elimination of supplemental
Medicare and Medicaid payments on which we depend, including
disproportionate share payments, indirect medical education/graduate
medical education payments, upper payment limit programs and other
similar payments; pressures to contain costs by managed care
organizations and other insurers and our ability to negotiate acceptable
terms with these third party payers; our ability to attract and retain
qualified management and health care professionals, including physicians
and nurses; the currently unknown effect on us of the major federal
health care reforms enacted by Congress in March 2010, including the
Patient Protection and Affordable Care Act, as amended by the Health
Care and Education Reconciliation Act of 2010, or other potential
additional federal or state health care reforms, including that states
may opt out of the Medicaid expansion; potential adverse impact of known
and unknown governmental investigations and audits; increased compliance
costs from further government regulation of the health care industry and
our failure to comply, or allegations of our failure to comply, with
applicable laws and regulations; our failure to adequately enhance our
facilities with technologically advanced equipment; the availability of
capital to fund our corporate growth strategy and improvements to our
existing facilities; potential lawsuits or other claims asserted against
us; our ability to maintain or increase patient membership in and to
control the costs of our managed health care plans; failure of AHCCCS to
renew its contract with, or award future contracts with similar terms
and scope to, Phoenix Health Plan; Phoenix Health Plan's ability to
comply with the terms of its contract with AHCCCS; our inability to
manage health plan claims expense within our health plans; reductions in
the enrollment of our health plans; changes in general economic
conditions nationally and regionally in our markets; our exposure to the
increased amounts of and collection risks associated with uninsured
accounts and the co-pay and deductible portions of insured accounts;
dependence on our senior management team and local management personnel;
volatility of professional and general liability insurance for us and
the physicians who practice at our hospitals and increases in the
quantity and severity of professional liability claims; our ability to
achieve operating and financial targets and to maintain and increase
patient volumes and control the costs of providing services, including
salaries and benefits, supplies and other operating expenses;
technological and pharmaceutical improvements that increase the cost of
providing, or reduce the demand for, health care services and shift
demand for inpatient services to outpatient settings; a failure of our
information systems; delays in receiving payments for services provided,
especially from governmental payers; changes in revenue mix, including
changes in Medicaid eligibility criteria and potential declines in the
population covered under managed care agreements; costs and compliance
risks associated with Section 404 of the Sarbanes-Oxley Act of 2002;
material non-cash charges to earnings from impairment of goodwill
associated with declines in the fair market value of our reporting
units; cash payments that may be necessary to fund an underfunded
defined benefit pension plan of the DMC; volatility of materials and
labor costs for, or state efforts to regulate, potential construction
projects that may be necessary for future growth; our reliance on
payments from our subsidiaries, which may be restricted by our credit
agreement and the indentures governing our senior notes; changes in
accounting practices; our ability to demonstrate meaningful use of
certified electronic health record technology and to receive the related
Medicare or Medicaid incentive payments; and other risk factors
described in our Annual Report on Form 10-K and other filings with the
Securities and Exchange Commission.
Our forward-looking statements speak only as of the date made. Except as
required by law, we undertake no obligation to publicly update or revise
any forward-looking statements contained herein, whether as a result of
new information, future events or otherwise. You are cautioned not to
rely on such forward-looking statements when evaluating the information
contained in this press release. In light of significant uncertainties
inherent in the forward-looking statements included in this press
release, you should not regard the inclusion of such information as a
representation by us that the objectives and plans anticipated by the
forward-looking statements will occur or be achieved or, if any of them
do, what impact they will have on our financial condition, results of
operations or cash flows.
We use our company website to provide important information to
investors about the company, including the posting of important
announcements regarding financial performance and corporate developments.
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Condensed Consolidated Statements of Operations (Unaudited)
|
(In millions, except share and per share amounts)
|
|
|
|
|
|
|
Quarter ended December 31,
|
|
|
2011
|
|
2012
|
Patient service revenues
|
|
$
|
1,428.1
|
|
|
96.8
|
%
|
|
$
|
1,481.5
|
|
|
97.9
|
%
|
Less: Provision for doubtful accounts
|
|
(141.5
|
)
|
|
(9.6
|
)
|
|
(161.7
|
)
|
|
(10.7
|
)
|
Patient service revenues, net
|
|
1,286.6
|
|
|
87.2
|
|
|
1,319.8
|
|
|
87.2
|
|
Premium revenues
|
|
188.8
|
|
|
12.8
|
|
|
193.3
|
|
|
12.8
|
|
Total revenues
|
|
1,475.4
|
|
|
100.0
|
|
|
1,513.1
|
|
|
100.0
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits (includes stock compensation)
|
|
702.4
|
|
|
47.6
|
|
|
698.1
|
|
|
46.1
|
|
Health plan claims expense
|
|
147.3
|
|
|
10.0
|
|
|
149.8
|
|
|
9.9
|
|
Supplies
|
|
227.9
|
|
|
15.4
|
|
|
232.5
|
|
|
15.4
|
|
Purchased services
|
|
133.4
|
|
|
9.0
|
|
|
148.2
|
|
|
9.8
|
|
Rents and leases
|
|
18.7
|
|
|
1.3
|
|
|
18.8
|
|
|
1.2
|
|
Other operating expenses
|
|
131.3
|
|
|
8.9
|
|
|
145.1
|
|
|
9.6
|
|
Medicare and Medicaid EHR incentives
|
|
(21.3
|
)
|
|
(1.4
|
)
|
|
(14.5
|
)
|
|
(1.0
|
)
|
Depreciation and amortization
|
|
65.8
|
|
|
4.5
|
|
|
67.8
|
|
|
4.5
|
|
Interest, net
|
|
43.2
|
|
|
2.9
|
|
|
49.7
|
|
|
3.3
|
|
Acquisition related expenses
|
|
0.4
|
|
|
-
|
|
|
0.1
|
|
|
-
|
|
Other
|
|
(1.8
|
)
|
|
(0.1
|
)
|
|
(1.8
|
)
|
|
(0.1
|
)
|
Income from continuing operations before income taxes
|
|
28.1
|
|
|
1.9
|
|
|
19.3
|
|
|
1.3
|
|
Income tax expense
|
|
(11.3
|
)
|
|
(0.8
|
)
|
|
(7.2
|
)
|
|
(0.5
|
)
|
Income from continuing operations
|
|
16.8
|
|
|
1.1
|
|
|
12.1
|
|
|
0.8
|
|
Loss from discontinued operations, net of taxes
|
|
(0.3
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
Net income
|
|
16.5
|
|
|
1.1
|
|
|
12.1
|
|
|
0.8
|
|
Net loss (income) attributable to non-controlling interests
|
|
(0.8
|
)
|
|
(0.1
|
)
|
|
0.1
|
|
|
-
|
|
Net income attributable to Vanguard Health Systems, Inc.
stockholders
|
|
$
|
15.7
|
|
|
1.1
|
%
|
|
$
|
12.2
|
|
|
0.8
|
%
|
|
|
|
|
|
|
|
|
|
Earnings per share attributable to Vanguard Health Systems, Inc.
stockholders
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
$
|
0.21
|
|
|
|
|
$
|
0.15
|
|
|
|
Diluted earnings per share
|
|
$
|
0.20
|
|
|
|
|
$
|
0.14
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding (in thousands):
|
|
|
|
|
|
|
|
|
Basic
|
|
75,325
|
|
|
|
|
77,421
|
|
|
|
Diluted
|
|
78,732
|
|
|
|
|
79,625
|
|
|
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Condensed Consolidated Statements of Operations (Unaudited)
|
(In millions, except share and per share amounts)
|
|
|
|
|
|
|
Six months ended December 31,
|
|
|
2011
|
|
2012
|
Patient service revenues
|
|
$
|
2,779.6
|
|
|
95.5
|
%
|
|
$
|
2,945.4
|
|
|
98.7
|
%
|
Less: Provision for doubtful accounts
|
|
(267.7
|
)
|
|
(9.2
|
)
|
|
(331.3
|
)
|
|
(11.1
|
)
|
Patient service revenues, net
|
|
2,511.9
|
|
|
86.3
|
|
|
2,614.1
|
|
|
87.6
|
|
Premium revenues
|
|
399.8
|
|
|
13.7
|
|
|
369.7
|
|
|
12.4
|
|
Total revenues
|
|
2,911.7
|
|
|
100.0
|
|
|
2,983.8
|
|
|
100.0
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits (includes stock compensation)
|
|
1,367.4
|
|
|
47.0
|
|
|
1,378.3
|
|
|
46.2
|
|
Health plan claims expense
|
|
312.0
|
|
|
10.7
|
|
|
284.1
|
|
|
9.5
|
|
Supplies
|
|
441.5
|
|
|
15.2
|
|
|
458.6
|
|
|
15.4
|
|
Purchased services
|
|
260.4
|
|
|
8.9
|
|
|
295.4
|
|
|
9.9
|
|
Rents and leases
|
|
36.7
|
|
|
1.3
|
|
|
37.8
|
|
|
1.3
|
|
Other operating expenses
|
|
264.4
|
|
|
9.1
|
|
|
289.3
|
|
|
9.7
|
|
Medicare and Medicaid EHR incentives
|
|
(24.4
|
)
|
|
(0.8
|
)
|
|
(25.8
|
)
|
|
(0.9
|
)
|
Depreciation and amortization
|
|
128.4
|
|
|
4.4
|
|
|
133.4
|
|
|
4.5
|
|
Interest, net
|
|
89.0
|
|
|
3.1
|
|
|
100.5
|
|
|
3.4
|
|
Debt extinguishment costs
|
|
38.9
|
|
|
1.3
|
|
|
-
|
|
|
-
|
|
Acquisition related expenses
|
|
12.6
|
|
|
0.4
|
|
|
0.1
|
|
|
-
|
|
Other
|
|
(4.2
|
)
|
|
(0.1
|
)
|
|
(6.9
|
)
|
|
(0.2
|
)
|
Income (loss) from continuing operations before income taxes
|
|
(11.0
|
)
|
|
(0.4
|
)
|
|
39.0
|
|
|
1.3
|
|
Income tax benefit (expense)
|
|
3.9
|
|
|
0.1
|
|
|
(12.1
|
)
|
|
(0.4
|
)
|
Income (loss) from continuing operations
|
|
(7.1
|
)
|
|
(0.2
|
)
|
|
26.9
|
|
|
0.9
|
|
Income (loss) from discontinued operations, net of taxes
|
|
(0.4
|
)
|
|
-
|
|
|
0.1
|
|
|
-
|
|
Net income (loss)
|
|
(7.5
|
)
|
|
(0.3
|
)
|
|
27.0
|
|
|
0.9
|
|
Net loss (income) attributable to non-controlling interests
|
|
1.5
|
|
|
0.1
|
|
|
(0.9
|
)
|
|
-
|
|
Net income (loss) attributable to Vanguard Health Systems, Inc.
stockholders
|
|
$
|
(6.0
|
)
|
|
(0.2
|
)%
|
|
$
|
26.1
|
|
|
0.9
|
%
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share attributable to Vanguard Health Systems,
Inc. stockholders
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share
|
|
$
|
(0.08
|
)
|
|
|
|
$
|
0.32
|
|
|
|
Diluted earnings (loss) per share
|
|
$
|
(0.08
|
)
|
|
|
|
$
|
0.31
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding (in thousands):
|
|
|
|
|
|
|
|
|
Basic
|
|
75,090
|
|
|
|
|
76,559
|
|
|
|
Diluted
|
|
75,090
|
|
|
|
|
79,205
|
|
|
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Supplemental Financial Information (Unaudited)
|
Reconciliation of Adjusted EBITDA to Net Income (Loss)
Attributable to Vanguard Health Systems, Inc. Stockholders
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended
|
|
Six months ended
|
|
|
December 31,
|
|
December 31,
|
|
|
2011
|
|
2012
|
|
2011
|
|
2012
|
Net income (loss) attributable to Vanguard Health Systems, Inc.
stockholders
|
|
$
|
15.7
|
|
|
$
|
12.2
|
|
|
$
|
(6.0
|
)
|
|
$
|
26.1
|
|
Interest, net
|
|
43.2
|
|
|
49.7
|
|
|
89.0
|
|
|
100.5
|
|
Income tax expense (benefit)
|
|
11.3
|
|
|
7.2
|
|
|
(3.9
|
)
|
|
12.1
|
|
Depreciation and amortization
|
|
65.8
|
|
|
67.8
|
|
|
128.4
|
|
|
133.4
|
|
Non-controlling interests
|
|
0.8
|
|
|
(0.1
|
)
|
|
(1.5
|
)
|
|
0.9
|
|
Loss (gain) on disposal of assets
|
|
0.4
|
|
|
1.9
|
|
|
(0.8
|
)
|
|
1.0
|
|
Equity method loss (income)
|
|
(0.6
|
)
|
|
0.2
|
|
|
(0.7
|
)
|
|
(0.4
|
)
|
Stock compensation
|
|
3.9
|
|
|
2.7
|
|
|
4.6
|
|
|
4.9
|
|
Realized losses on investments
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.2
|
|
Acquisition related expenses
|
|
0.4
|
|
|
0.1
|
|
|
12.6
|
|
|
0.1
|
|
Debt extinguishment costs
|
|
-
|
|
|
-
|
|
|
38.9
|
|
|
-
|
|
Impairment and restructuring charges
|
|
-
|
|
|
-
|
|
|
(0.1
|
)
|
|
-
|
|
Pension credits
|
|
(1.6
|
)
|
|
(3.9
|
)
|
|
(2.6
|
)
|
|
(7.7
|
)
|
Discontinued operations, net of taxes
|
|
0.3
|
|
|
-
|
|
|
0.4
|
|
|
(0.1
|
)
|
Adjusted EBITDA(1)
|
|
$
|
139.6
|
|
|
$
|
137.8
|
|
|
$
|
258.3
|
|
|
$
|
271.0
|
|
____________________
|
(1) Adjusted EBITDA is defined as income (loss) before interest
expense (net of interest income), income taxes, depreciation and
amortization, non-controlling interests, gain or loss on disposal
of assets, equity method income or loss, stock compensation,
realized gains or losses on investments, acquisition related
expenses, debt extinguishment costs, impairment and restructuring
charges, pension expense (credits) and discontinued operations,
net of taxes. Adjusted EBITDA is not intended as a substitute for
net income (loss) attributable to Vanguard Health Systems, Inc.
stockholders, operating cash flows or other cash flow data
determined in accordance with accounting principles generally
accepted in the United States. Due to varying methods of
calculation, Adjusted EBITDA as presented may not be comparable to
similarly titled measures of other companies.
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Condensed Consolidated Balance Sheets (Unaudited)
|
(In millions)
|
|
|
|
|
|
|
|
June 30, 2012
|
|
December 31, 2012
|
ASSETS
|
|
|
|
|
Current assets:
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
455.5
|
|
|
$
|
357.8
|
|
Restricted cash
|
|
2.4
|
|
|
5.7
|
|
Accounts receivable, net of allowance for doubtful accounts of
$366.5 and $382.1, respectively
|
|
702.1
|
|
|
666.4
|
|
Inventories
|
|
97.0
|
|
|
96.6
|
|
Deferred tax assets
|
|
89.6
|
|
|
71.0
|
|
Prepaid expenses and other current assets
|
|
236.4
|
|
|
197.1
|
|
Total current assets
|
|
1,583.0
|
|
|
1,394.6
|
|
Property, plant and equipment, net of accumulated depreciation
|
|
2,110.1
|
|
|
2,145.3
|
|
Goodwill
|
|
768.4
|
|
|
772.7
|
|
Intangible assets, net of accumulated amortization
|
|
89.0
|
|
|
87.8
|
|
Deferred tax assets, noncurrent
|
|
71.2
|
|
|
82.9
|
|
Investments in securities
|
|
51.8
|
|
|
57.9
|
|
Escrowed cash for capital commitments
|
|
20.3
|
|
|
-
|
|
Other assets
|
|
94.3
|
|
|
97.2
|
|
Total assets
|
|
$
|
4,788.1
|
|
|
$
|
4,638.4
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Accounts payable
|
|
$
|
390.6
|
|
|
$
|
369.1
|
|
Accrued salaries and benefits
|
|
226.0
|
|
|
220.5
|
|
Accrued health plan claims and settlements
|
|
67.8
|
|
|
63.0
|
|
Accrued interest
|
|
73.2
|
|
|
73.4
|
|
Other accrued expenses and current liabilities
|
|
219.9
|
|
|
162.8
|
|
Current maturities of long-term debt
|
|
11.2
|
|
|
12.6
|
|
Total current liabilities
|
|
988.7
|
|
|
901.4
|
|
Professional and general liability and workers compensation reserves
|
|
304.8
|
|
|
305.7
|
|
Unfunded pension liability
|
|
269.9
|
|
|
229.9
|
|
Other liabilities
|
|
174.7
|
|
|
123.1
|
|
Long-term debt, less current maturities
|
|
2,695.4
|
|
|
2,690.6
|
|
Commitments and contingencies
|
|
|
|
|
Redeemable non-controlling interests
|
|
53.1
|
|
|
55.3
|
|
Equity:
|
|
|
|
|
Vanguard Health Systems, Inc. stockholders' equity:
|
|
|
|
|
Common stock
|
|
0.8
|
|
|
0.8
|
|
Additional paid-in capital
|
|
403.3
|
|
|
405.0
|
|
Accumulated other comprehensive loss
|
|
(48.4
|
)
|
|
(46.5
|
)
|
Retained deficit
|
|
(60.6
|
)
|
|
(34.5
|
)
|
Total Vanguard Health Systems, Inc. stockholders' equity
|
|
295.1
|
|
|
324.8
|
|
Non-controlling interests
|
|
6.4
|
|
|
7.6
|
|
Total equity
|
|
301.5
|
|
|
332.4
|
|
Total liabilities and equity
|
|
$
|
4,788.1
|
|
|
$
|
4,638.4
|
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Condensed Consolidated Statements of Cash Flows (Unaudited)
|
(In millions)
|
|
|
Six months ended
|
|
|
December 31,
|
|
|
2011
|
|
2012
|
Operating activities:
|
|
|
|
|
Net income (loss)
|
|
$
|
(7.5
|
)
|
|
$
|
27.0
|
|
Adjustments to reconcile net income (loss) to net cash provided by
operating activities:
|
|
|
|
|
Loss (income) from discontinued operations
|
|
0.4
|
|
|
(0.1
|
)
|
Depreciation and amortization
|
|
128.4
|
|
|
133.4
|
|
Amortization of loan costs and accretion of principal on notes
|
|
8.4
|
|
|
6.6
|
|
Acquisition related expenses
|
|
12.6
|
|
|
0.1
|
|
Stock compensation
|
|
4.6
|
|
|
4.9
|
|
Deferred income taxes
|
|
(5.9
|
)
|
|
7.0
|
|
Debt extinguishment costs
|
|
38.9
|
|
|
-
|
|
Other
|
|
(1.1
|
)
|
|
1.2
|
|
Changes in operating assets and liabilities, net of the impact of
acquisitions
|
|
(172.2
|
)
|
|
(92.9
|
)
|
Net cash provided by operating activities - continuing operations
|
|
6.6
|
|
|
87.2
|
|
Net cash provided by (used in) operating activities - discontinued
operations
|
|
(0.4
|
)
|
|
0.1
|
|
Net cash provided by operating activities
|
|
6.2
|
|
|
87.3
|
|
|
|
|
|
|
Investing activities:
|
|
|
|
|
Acquisitions and related expenses, net of cash acquired
|
|
(208.8
|
)
|
|
(7.2
|
)
|
Capital expenditures
|
|
(137.2
|
)
|
|
(187.2
|
)
|
Proceeds from sales of investments in securities
|
|
42.3
|
|
|
76.1
|
|
Purchases of investments in securities
|
|
(30.4
|
)
|
|
(79.1
|
)
|
Net reimbursements from restricted cash and escrow fund
|
|
-
|
|
|
17.8
|
|
Other investing activities
|
|
(0.7
|
)
|
|
1.3
|
|
Net cash used in investing activities
|
|
(334.8
|
)
|
|
(178.3
|
)
|
|
|
|
|
|
Financing activities:
|
|
|
|
|
Payments of long-term debt and capital leases
|
|
(460.7
|
)
|
|
(5.5
|
)
|
Proceeds from the issuance of common stock
|
|
67.5
|
|
|
-
|
|
Payments of IPO related costs
|
|
(6.9
|
)
|
|
-
|
|
Payments of tender premiums on note redemptions
|
|
(27.6
|
)
|
|
-
|
|
Other financing activities
|
|
(1.6
|
)
|
|
(1.2
|
)
|
Net cash used in financing activities
|
|
(429.3
|
)
|
|
(6.7
|
)
|
Net decrease in cash and cash equivalents
|
|
(757.9
|
)
|
|
(97.7
|
)
|
Cash and cash equivalents, beginning of period
|
|
936.6
|
|
|
455.5
|
|
Cash and cash equivalents, end of period
|
|
$
|
178.7
|
|
|
$
|
357.8
|
|
|
|
|
|
|
Supplemental cash flow information:
|
|
|
|
|
Net cash paid for interest
|
|
$
|
81.0
|
|
|
$
|
93.8
|
|
Net cash paid for income taxes
|
|
$
|
0.6
|
|
|
$
|
4.4
|
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Segment Information (Unaudited)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended December 31, 2011
|
|
|
Acute Care
|
|
% of
|
|
Health
|
|
% of
|
|
|
|
|
|
|
Services
|
|
Revenues
|
|
Plans
|
|
Revenues
|
|
Eliminations
|
|
Consolidated
|
Patient service revenues, net(1)
|
|
$
|
1,297.1
|
|
|
100.0
|
%
|
|
$
|
-
|
|
|
-
|
%
|
|
$
|
(10.5
|
)
|
|
$
|
1,286.6
|
|
Premium revenues
|
|
-
|
|
|
-
|
|
|
188.8
|
|
|
100.0
|
|
|
-
|
|
|
188.8
|
|
Total revenues
|
|
1,297.1
|
|
|
100.0
|
|
|
188.8
|
|
|
100.0
|
|
|
(10.5
|
)
|
|
1,475.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits (excludes stock compensation)
|
|
689.2
|
|
|
53.1
|
|
|
9.3
|
|
|
4.9
|
|
|
-
|
|
|
698.5
|
|
Health plan claims expense(1)
|
|
-
|
|
|
-
|
|
|
157.8
|
|
|
83.6
|
|
|
(10.5
|
)
|
|
147.3
|
|
Supplies
|
|
227.9
|
|
|
17.6
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
227.9
|
|
Other operating expenses
|
|
271.2
|
|
|
20.9
|
|
|
12.2
|
|
|
6.5
|
|
|
-
|
|
|
283.4
|
|
Medicare and Medicaid
EHR incentives
|
|
(21.3
|
)
|
|
(1.6
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(21.3
|
)
|
Segment EBITDA(2)
|
|
130.1
|
|
|
10.0
|
|
|
9.5
|
|
|
5.0
|
|
|
-
|
|
|
139.6
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest, net
|
|
43.8
|
|
|
3.4
|
|
|
(0.6
|
)
|
|
(0.3
|
)
|
|
-
|
|
|
43.2
|
|
Depreciation and amortization
|
|
64.6
|
|
|
5.0
|
|
|
1.2
|
|
|
0.6
|
|
|
-
|
|
|
65.8
|
|
Equity method income
|
|
(0.6
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(0.6
|
)
|
Stock compensation
|
|
3.9
|
|
|
0.3
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
3.9
|
|
Loss on disposal of assets
|
|
0.4
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.4
|
|
Acquisition related expenses
|
|
0.4
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.4
|
|
Pension credits
|
|
(1.6
|
)
|
|
(0.1
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(1.6
|
)
|
Income from continuing operations before income taxes
|
|
$
|
19.2
|
|
|
1.5
|
%
|
|
$
|
8.9
|
|
|
4.7
|
%
|
|
$
|
-
|
|
|
$
|
28.1
|
|
___________________
|
(1) We eliminate in consolidation those patient service revenues
earned by our health care facilities attributable to services
provided to enrollees in our owned health plans and eliminate the
corresponding medical claims expenses incurred by our health plans
for those services.
|
|
(2) Segment EBITDA is defined as income (loss) from continuing
operations before income taxes less interest expense (net of
interest income), depreciation and amortization, equity method
income or loss, stock compensation, gain or loss on disposal of
assets, realized gains or losses on investments, acquisition
related expenses, debt extinguishment costs, impairment and
restructuring charges and pension expense (credits). Management
uses Segment EBITDA to measure the performance of our segments and
develop strategic objectives and operating plans for those
segments. Segment EBITDA eliminates the uneven effect of non-cash
depreciation of tangible assets and amortization of intangible
assets, much of which results from acquisitions accounted for
under the purchase method of accounting. Segment EBITDA also
eliminates the effects of changes in interest rates, which
management believes relate to general trends in global capital
markets, but are not necessarily indicative of the operating
performance of our segments. Management believes that Segment
EBITDA provides useful information to investors, lenders,
financial analysts and rating agencies about the financial
performance of our segments. Additionally, management believes
that investors and lenders view Segment EBITDA as an important
factor in making investment decisions concerning us. Segment
EBITDA is not a substitute for net income (loss), operating cash
flows or other cash flow statement data determined in accordance
with accounting principles generally accepted in the United
States. Segment EBITDA, as presented, may not be comparable to
similar measures of other companies.
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Segment Information (Unaudited) (continued)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended December 31, 2012
|
|
|
Acute Care
|
|
% of
|
|
Health
|
|
% of
|
|
|
|
|
|
|
Services
|
|
Revenues
|
|
Plans
|
|
Revenues
|
|
Eliminations
|
|
Consolidated
|
Patient service revenues, net(1)
|
|
$
|
1,329.3
|
|
|
100.0
|
%
|
|
$
|
-
|
|
|
-
|
%
|
|
$
|
(9.5
|
)
|
|
$
|
1,319.8
|
|
Premium revenues
|
|
-
|
|
|
-
|
|
|
193.3
|
|
|
100.0
|
|
|
-
|
|
|
193.3
|
|
Total revenues
|
|
1,329.3
|
|
|
100.0
|
|
|
193.3
|
|
|
100.0
|
|
|
(9.5
|
)
|
|
1,513.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits (excludes stock compensation)
|
|
685.3
|
|
|
51.6
|
|
|
10.1
|
|
|
5.2
|
|
|
-
|
|
|
695.4
|
|
Health plan claims expense(1)
|
|
-
|
|
|
-
|
|
|
159.3
|
|
|
82.4
|
|
|
(9.5
|
)
|
|
149.8
|
|
Supplies
|
|
232.4
|
|
|
17.5
|
|
|
0.1
|
|
|
0.1
|
|
|
-
|
|
|
232.5
|
|
Other operating expenses
|
|
301.1
|
|
|
22.7
|
|
|
11.0
|
|
|
5.7
|
|
|
-
|
|
|
312.1
|
|
Medicare and Medicaid
EHR incentives
|
|
(14.5
|
)
|
|
(1.1
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(14.5
|
)
|
Segment EBITDA(2)
|
|
125.0
|
|
|
9.4
|
|
|
12.8
|
|
|
6.6
|
|
|
-
|
|
|
137.8
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest, net
|
|
50.3
|
|
|
3.8
|
|
|
(0.6
|
)
|
|
(0.3
|
)
|
|
-
|
|
|
49.7
|
|
Depreciation and amortization
|
|
66.7
|
|
|
5.0
|
|
|
1.1
|
|
|
0.6
|
|
|
-
|
|
|
67.8
|
|
Equity method loss
|
|
0.2
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.2
|
|
Stock compensation
|
|
2.7
|
|
|
0.2
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
2.7
|
|
Loss on disposal of assets
|
|
1.9
|
|
|
0.1
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1.9
|
|
Acquisition related expenses
|
|
0.1
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.1
|
|
Pension credits
|
|
(3.9
|
)
|
|
(0.3
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(3.9
|
)
|
Income from continuing operations before income taxes
|
|
$
|
7.0
|
|
|
0.5
|
%
|
|
$
|
12.3
|
|
|
6.5
|
%
|
|
$
|
-
|
|
|
$
|
19.3
|
|
__________________
|
(1) We eliminate in consolidation those patient service revenues
earned by our health care facilities attributable to services
provided to enrollees in our owned health plans and eliminate the
corresponding medical claims expenses incurred by our health plans
for those services.
|
|
(2) Segment EBITDA is defined as income (loss) from continuing
operations before income taxes less interest expense (net of
interest income), depreciation and amortization, equity method
income or loss, stock compensation, gain or loss on disposal of
assets, realized gains or losses on investments, acquisition
related expenses, debt extinguishment costs, impairment and
restructuring charges and pension expense (credits). Management
uses Segment EBITDA to measure the performance of our segments and
develop strategic objectives and operating plans for those
segments. Segment EBITDA eliminates the uneven effect of non-cash
depreciation of tangible assets and amortization of intangible
assets, much of which results from acquisitions accounted for
under the purchase method of accounting. Segment EBITDA also
eliminates the effects of changes in interest rates, which
management believes relate to general trends in global capital
markets, but are not necessarily indicative of the operating
performance of our segments. Management believes that Segment
EBITDA provides useful information to investors, lenders,
financial analysts and rating agencies about the financial
performance of our segments. Additionally, management believes
that investors and lenders view Segment EBITDA as an important
factor in making investment decisions concerning us. Segment
EBITDA is not a substitute for net income (loss), operating cash
flows or other cash flow statement data determined in accordance
with accounting principles generally accepted in the United
States. Segment EBITDA, as presented, may not be comparable to
similar measures of other companies.
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Segment Information (Unaudited) (continued)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended December 31, 2011
|
|
|
Acute Care
|
|
% of
|
|
Health
|
|
% of
|
|
|
|
|
|
|
Services
|
|
Revenues
|
|
Plans
|
|
Revenues
|
|
Eliminations
|
|
Consolidated
|
Patient service revenues, net(1)
|
|
$
|
2,531.0
|
|
|
100.0
|
%
|
|
$
|
-
|
|
|
-
|
%
|
|
$
|
(19.1
|
)
|
|
$
|
2,511.9
|
|
Premium revenues
|
|
-
|
|
|
-
|
|
|
399.8
|
|
|
100.0
|
|
|
-
|
|
|
399.8
|
|
Total revenues
|
|
2,531.0
|
|
|
100.0
|
|
|
399.8
|
|
|
100.0
|
|
|
(19.1
|
)
|
|
2,911.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits (excludes stock compensation)
|
|
1,344.5
|
|
|
53.1
|
|
|
18.3
|
|
|
4.6
|
|
|
-
|
|
|
1,362.8
|
|
Health plan claims expense(1)
|
|
-
|
|
|
-
|
|
|
331.1
|
|
|
82.8
|
|
|
(19.1
|
)
|
|
312.0
|
|
Supplies
|
|
441.4
|
|
|
17.4
|
|
|
0.1
|
|
|
-
|
|
|
-
|
|
|
441.5
|
|
Other operating expenses
|
|
538.6
|
|
|
21.3
|
|
|
22.9
|
|
|
5.7
|
|
|
-
|
|
|
561.5
|
|
Medicare and Medicaid
EHR incentives
|
|
(24.4
|
)
|
|
(1.0
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(24.4
|
)
|
Segment EBITDA(2)
|
|
230.9
|
|
|
9.1
|
|
|
27.4
|
|
|
6.9
|
|
|
-
|
|
|
258.3
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest, net
|
|
89.9
|
|
|
3.6
|
|
|
(0.9
|
)
|
|
(0.2
|
)
|
|
-
|
|
|
89.0
|
|
Depreciation and amortization
|
|
126.1
|
|
|
5.0
|
|
|
2.3
|
|
|
0.6
|
|
|
-
|
|
|
128.4
|
|
Equity method income
|
|
(0.7
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(0.7
|
)
|
Stock compensation
|
|
4.6
|
|
|
0.2
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
4.6
|
|
Gain on disposal of assets
|
|
(0.8
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(0.8
|
)
|
Acquisition related expenses
|
|
12.6
|
|
|
0.5
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
12.6
|
|
Debt extinguishment costs
|
|
38.9
|
|
|
1.5
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
38.9
|
|
Impairment and restructuring charges
|
|
(0.1
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(0.1
|
)
|
Pension credits
|
|
(2.6
|
)
|
|
(0.1
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(2.6
|
)
|
Income (loss) from continuing operations before income taxes
|
|
$
|
(37.0
|
)
|
|
(1.5
|
)%
|
|
$
|
26.0
|
|
|
6.5
|
%
|
|
$
|
-
|
|
|
$
|
(11.0
|
)
|
__________________
|
(1) We eliminate in consolidation those patient service revenues
earned by our health care facilities attributable to services
provided to enrollees in our owned health plans and eliminate the
corresponding medical claims expenses incurred by our health plans
for those services.
|
|
(2) Segment EBITDA is defined as income (loss) from continuing
operations before income taxes less interest expense (net of
interest income), depreciation and amortization, equity method
income or loss, stock compensation, gain or loss on disposal of
assets, realized gains or losses on investments, acquisition
related expenses, debt extinguishment costs, impairment and
restructuring charges and pension expense (credits). Management
uses Segment EBITDA to measure the performance of our segments and
develop strategic objectives and operating plans for those
segments. Segment EBITDA eliminates the uneven effect of non-cash
depreciation of tangible assets and amortization of intangible
assets, much of which results from acquisitions accounted for
under the purchase method of accounting. Segment EBITDA also
eliminates the effects of changes in interest rates, which
management believes relate to general trends in global capital
markets, but are not necessarily indicative of the operating
performance of our segments. Management believes that Segment
EBITDA provides useful information to investors, lenders,
financial analysts and rating agencies about the financial
performance of our segments. Additionally, management believes
that investors and lenders view Segment EBITDA as an important
factor in making investment decisions concerning us. Segment
EBITDA is not a substitute for net income (loss), operating cash
flows or other cash flow statement data determined in accordance
with accounting principles generally accepted in the United
States. Segment EBITDA, as presented, may not be comparable to
similar measures of other companies.
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Segment Information (Unaudited) (continued)
|
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended December 31, 2012
|
|
|
Acute Care
|
|
% of
|
|
Health
|
|
% of
|
|
|
|
|
|
|
Services
|
|
Revenues
|
|
Plans
|
|
Revenues
|
|
Eliminations
|
|
Consolidated
|
Patient service revenues, net(1)
|
|
$
|
2,633.8
|
|
|
100.0
|
%
|
|
$
|
-
|
|
|
-
|
%
|
|
$
|
(19.7
|
)
|
|
$
|
2,614.1
|
|
Premium revenues
|
|
-
|
|
|
-
|
|
|
369.7
|
|
|
100.0
|
|
|
-
|
|
|
369.7
|
|
Total revenues
|
|
2,633.8
|
|
|
100.0
|
|
|
369.7
|
|
|
100.0
|
|
|
(19.7
|
)
|
|
2,983.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits (excludes stock compensation)
|
|
1,354.4
|
|
|
51.4
|
|
|
19.0
|
|
|
5.1
|
|
|
-
|
|
|
1,373.4
|
|
Health plan claims expense(1)
|
|
-
|
|
|
-
|
|
|
303.8
|
|
|
82.2
|
|
|
(19.7
|
)
|
|
284.1
|
|
Supplies
|
|
458.5
|
|
|
17.4
|
|
|
0.1
|
|
|
-
|
|
|
-
|
|
|
458.6
|
|
Other operating expenses
|
|
600.3
|
|
|
22.8
|
|
|
22.2
|
|
|
6.0
|
|
|
-
|
|
|
622.5
|
|
Medicare and Medicaid
EHR incentives
|
|
(25.8
|
)
|
|
(1.0
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(25.8
|
)
|
Segment EBITDA(2)
|
|
246.4
|
|
|
9.4
|
|
|
24.6
|
|
|
6.7
|
|
|
-
|
|
|
271.0
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest, net
|
|
101.6
|
|
|
3.9
|
|
|
(1.1
|
)
|
|
(0.3
|
)
|
|
-
|
|
|
100.5
|
|
Depreciation and amortization
|
|
131.3
|
|
|
5.0
|
|
|
2.1
|
|
|
0.6
|
|
|
-
|
|
|
133.4
|
|
Equity method income
|
|
(0.4
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(0.4
|
)
|
Stock compensation
|
|
4.9
|
|
|
0.2
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
4.9
|
|
Loss on disposal of assets
|
|
1.0
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
1.0
|
|
Realized losses on investments
|
|
0.2
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.2
|
|
Acquisition related expenses
|
|
0.1
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
0.1
|
|
Pension credits
|
|
(7.7
|
)
|
|
(0.3
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(7.7
|
)
|
Income from continuing operations before income taxes
|
|
$
|
15.4
|
|
|
0.6
|
%
|
|
$
|
23.6
|
|
|
6.5
|
%
|
|
$
|
-
|
|
|
$
|
39.0
|
|
__________________
|
(1) We eliminate in consolidation those patient service revenues
earned by our health care facilities attributable to services
provided to enrollees in our owned health plans and eliminate the
corresponding medical claims expenses incurred by our health plans
for those services.
|
|
(2) Segment EBITDA is defined as income (loss) from continuing
operations before income taxes less interest expense (net of
interest income), depreciation and amortization, equity method
income or loss, stock compensation, gain or loss on disposal of
assets, realized gains or losses on investments, acquisition
related expenses, debt extinguishment costs, impairment and
restructuring charges and pension expense (credits). Management
uses Segment EBITDA to measure the performance of our segments and
develop strategic objectives and operating plans for those
segments. Segment EBITDA eliminates the uneven effect of non-cash
depreciation of tangible assets and amortization of intangible
assets, much of which results from acquisitions accounted for
under the purchase method of accounting. Segment EBITDA also
eliminates the effects of changes in interest rates, which
management believes relate to general trends in global capital
markets, but are not necessarily indicative of the operating
performance of our segments. Management believes that Segment
EBITDA provides useful information to investors, lenders,
financial analysts and rating agencies about the financial
performance of our segments. Additionally, management believes
that investors and lenders view Segment EBITDA as an important
factor in making investment decisions concerning us. Segment
EBITDA is not a substitute for net income (loss), operating cash
flows or other cash flow statement data determined in accordance
with accounting principles generally accepted in the United
States. Segment EBITDA, as presented, may not be comparable to
similar measures of other companies.
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Selected Operating Statistics
|
(Unaudited)
|
|
|
|
Quarter ended
|
|
|
CONSOLIDATED AND SAME STORE:
|
|
December 31,
|
|
|
|
|
2011
|
|
2012
|
|
% Change
|
Number of hospitals at end of period
|
|
28
|
|
|
28
|
|
|
|
Licensed beds at end of period
|
|
7,064
|
|
|
7,064
|
|
|
|
Discharges
|
|
71,961
|
|
|
70,980
|
|
|
(1.4
|
)%
|
Adjusted discharges
|
|
129,089
|
|
|
130,924
|
|
|
1.4
|
|
Average length of stay
|
|
4.39
|
|
|
4.47
|
|
|
1.8
|
|
Patient days
|
|
316,075
|
|
|
317,369
|
|
|
0.4
|
|
Adjusted patient days
|
|
566,997
|
|
|
585,394
|
|
|
3.2
|
|
Patient revenue per adjusted discharge
|
|
$
|
9,506
|
|
|
$
|
9,647
|
|
|
1.5
|
|
Inpatient surgeries
|
|
16,910
|
|
|
16,345
|
|
|
(3.3
|
)
|
Outpatient surgeries
|
|
31,876
|
|
|
31,444
|
|
|
(1.4
|
)
|
Observation cases
|
|
17,750
|
|
|
19,170
|
|
|
8.0
|
|
Emergency room visits
|
|
299,075
|
|
|
317,069
|
|
|
6.0
|
|
Health plan member lives
|
|
249,500
|
|
|
236,000
|
|
|
(5.4
|
)
|
Health plan claims expense percentage
|
|
78.0
|
%
|
|
77.5
|
%
|
|
|
|
|
|
|
|
|
|
Uncompensated care as a percent of net patient revenues (prior to
uncompensated care deductions)
|
|
20.0
|
%
|
|
21.3
|
%
|
|
|
|
|
|
|
|
|
|
Net patient revenue payer mix:
|
|
|
|
|
|
|
Medicare
|
|
28.2
|
%
|
|
27.1
|
%
|
|
|
Medicaid
|
|
13.9
|
|
|
13.4
|
|
|
|
Managed Medicare
|
|
11.1
|
|
|
11.7
|
|
|
|
Managed Medicaid
|
|
8.7
|
|
|
10.2
|
|
|
|
Managed care
|
|
34.5
|
|
|
34.1
|
|
|
|
Commercial
|
|
1.2
|
|
|
1.5
|
|
|
|
Self-pay
|
|
2.4
|
|
|
2.0
|
|
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Discharges by payer:
|
|
|
|
|
|
|
Medicare
|
|
29.5
|
%
|
|
29.1
|
%
|
|
|
Medicaid
|
|
11.8
|
|
|
9.8
|
|
|
|
Managed Medicare
|
|
12.1
|
|
|
12.7
|
|
|
|
Managed Medicaid
|
|
16.4
|
|
|
18.2
|
|
|
|
Managed care
|
|
22.8
|
|
|
22.3
|
|
|
|
Commercial
|
|
0.5
|
|
|
0.5
|
|
|
|
Self-pay
|
|
6.9
|
|
|
7.4
|
|
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Selected Operating Statistics
|
(Unaudited) (continued)
|
|
|
|
Six months ended
|
|
|
CONSOLIDATED:
|
|
December 31,
|
|
|
|
|
2011
|
|
2012
|
|
% Change
|
Number of hospitals at end of period
|
|
28
|
|
|
28
|
|
|
|
Licensed beds at end of period
|
|
7,064
|
|
|
7,064
|
|
|
|
Discharges
|
|
140,122
|
|
|
142,461
|
|
|
1.7
|
%
|
Adjusted discharges
|
|
254,345
|
|
|
262,430
|
|
|
3.2
|
|
Average length of stay
|
|
4.37
|
|
|
4.44
|
|
|
1.6
|
|
Patient days
|
|
612,154
|
|
|
632,924
|
|
|
3.4
|
|
Adjusted patient days
|
|
1,111,161
|
|
|
1,165,919
|
|
|
4.9
|
|
Patient revenue per adjusted discharge
|
|
$
|
9,397
|
|
|
$
|
9,525
|
|
|
1.4
|
|
Inpatient surgeries
|
|
32,987
|
|
|
32,937
|
|
|
(0.2
|
)
|
Outpatient surgeries
|
|
61,852
|
|
|
62,575
|
|
|
1.2
|
|
Observation cases
|
|
34,107
|
|
|
38,398
|
|
|
12.6
|
|
Emergency room visits
|
|
591,914
|
|
|
632,104
|
|
|
6.8
|
|
Health plan member lives
|
|
249,500
|
|
|
236,000
|
|
|
(5.4
|
)
|
Health plan claims expense percentage
|
|
78.0
|
%
|
|
76.8
|
%
|
|
|
|
|
|
|
|
|
|
Uncompensated care as a percent of net patient revenues (prior to
uncompensated care deductions)
|
|
19.0
|
%
|
|
21.5
|
%
|
|
|
|
|
|
|
|
|
|
Net patient revenue payer mix:
|
|
|
|
|
|
|
Medicare
|
|
27.4
|
%
|
|
27.3
|
%
|
|
|
Medicaid
|
|
14.3
|
|
|
13.5
|
|
|
|
Managed Medicare
|
|
10.7
|
|
|
11.5
|
|
|
|
Managed Medicaid
|
|
9.6
|
|
|
10.1
|
|
|
|
Managed care
|
|
34.8
|
|
|
34.1
|
|
|
|
Commercial
|
|
1.3
|
|
|
1.5
|
|
|
|
Self-pay
|
|
1.9
|
|
|
2.0
|
|
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Discharges by payer:
|
|
|
|
|
|
|
Medicare
|
|
28.9
|
%
|
|
28.5
|
%
|
|
|
Medicaid
|
|
11.2
|
|
|
9.7
|
|
|
|
Managed Medicare
|
|
12.2
|
|
|
12.5
|
|
|
|
Managed Medicaid
|
|
17.1
|
|
|
18.4
|
|
|
|
Managed care
|
|
23.0
|
|
|
22.5
|
|
|
|
Commercial
|
|
0.5
|
|
|
0.5
|
|
|
|
Self-pay
|
|
7.1
|
|
|
7.9
|
|
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
VANGUARD HEALTH SYSTEMS, INC.
|
Selected Operating Statistics
|
(Unaudited) (continued)
|
|
|
|
Six months ended
|
|
|
SAME STORE:
|
|
December 31,
|
|
|
|
|
2011
|
|
2012
|
|
% Change
|
Number of hospitals at end of period
|
|
26
|
|
|
26
|
|
|
|
Licensed beds at end of period
|
|
6,198
|
|
|
6,198
|
|
|
|
Total revenues, including premium revenues (in millions)
|
|
$
|
2,771.4
|
|
|
$
|
2,769.0
|
|
|
(0.1
|
)%
|
Net patient service revenues (in millions)
|
|
$
|
2,382.7
|
|
|
$
|
2,420.8
|
|
|
1.6
|
|
Discharges
|
|
130,868
|
|
|
128,520
|
|
|
(1.8
|
)
|
Adjusted discharges
|
|
241,323
|
|
|
240,792
|
|
|
(0.2
|
)
|
Average length of stay
|
|
4.34
|
|
|
4.42
|
|
|
1.8
|
|
Patient days
|
|
567,700
|
|
|
567,483
|
|
|
-
|
|
Adjusted patient days
|
|
1,046,849
|
|
|
1,063,223
|
|
|
1.6
|
|
Patient revenue per adjusted discharge
|
|
$
|
9,383
|
|
|
$
|
9,598
|
|
|
2.3
|
|
Inpatient surgeries
|
|
30,205
|
|
|
28,921
|
|
|
(4.3
|
)
|
Outpatient surgeries
|
|
58,605
|
|
|
57,401
|
|
|
(2.1
|
)
|
Observation cases
|
|
31,799
|
|
|
34,683
|
|
|
9.1
|
|
Emergency room visits
|
|
565,499
|
|
|
586,747
|
|
|
3.8
|
|
Health plan claims expense percentage
|
|
78.2
|
%
|
|
76.8
|
%
|
|
|
|
|
|
|
|
|
|
Uncompensated care as a percent of net patient revenues (prior to
uncompensated care deductions)
|
|
18.0
|
%
|
|
20.2
|
%
|
|
|
|
|
|
|
|
|
|
Net patient revenue payer mix:
|
|
|
|
|
|
|
Medicare
|
|
26.7
|
%
|
|
26.3
|
%
|
|
|
Medicaid
|
|
14.1
|
|
|
13.4
|
|
|
|
Managed Medicare
|
|
10.9
|
|
|
11.7
|
|
|
|
Managed Medicaid
|
|
10.3
|
|
|
10.5
|
|
|
|
Managed care
|
|
35.0
|
|
|
34.7
|
|
|
|
Commercial
|
|
1.4
|
|
|
1.5
|
|
|
|
Self-pay
|
|
1.6
|
|
|
1.9
|
|
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Discharges by payer:
|
|
|
|
|
|
|
Medicare
|
|
28.6
|
%
|
|
28.3
|
%
|
|
|
Medicaid
|
|
10.0
|
|
|
9.3
|
|
|
|
Managed Medicare
|
|
12.7
|
|
|
13.1
|
|
|
|
Managed Medicaid
|
|
18.2
|
|
|
18.0
|
|
|
|
Managed care
|
|
23.3
|
|
|
23.0
|
|
|
|
Commercial
|
|
0.5
|
|
|
0.6
|
|
|
|
Self-pay
|
|
6.7
|
|
|
7.7
|
|
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[ Back To TMCnet.com's Homepage ]
|